In a pioneering alliance, the World Association for Integrative Oncology (WAIO), an international leader in holistic cancer care, and OncoDaily, a renowned global oncology media platform, have entered a Strategic Partnership Agreement to advance integrativeoncology and foster global collaboration in cancer care and research.Signed on November 17, 2024, this partnership establishes a cooperative framework aimed at advancing cancer care through innovation and education.As part of the agreement, OncoDaily becomes WAIO’s Official Media Partner, amplifying the impact of WAIO’s annual meetings, educational programs, and other major initiatives.Key Highlights of the WAIO and OncoDaily PartnershipAdvancing Global Cancer Care and Research◆ Joint efforts to promote integrative oncology as a key approach in improving global cancer care outcomes.◆ Fostering innovation and sharing advancements in oncology practices worldwide.OncoDaily as the Official Media Partner◆ Coverage and promotion of WAIO’s annual meetings, educational events, and significant oncology activities.◆ Amplifying WAIO’s initiatives to a global audience through OncoDaily’s extensive media platform.Educational and Scientific Initiatives◆ Co-hosting global educational and scientific events focused on integrative oncology.◆ Collaborating on the development of joint scientific journals and publications to disseminate cutting-edge research.Global Knowledge Sharing◆ Highlighting WAIO’s contributions, achievements, and advancements in integrative oncology through OncoDaily’s network.◆ Encouraging cross-border collaboration and knowledge exchange among oncology professionals, researchers, and institutions.Holistic Approach to Cancer Care◆ Promoting a model of cancer care that combines traditional healing practices with modern oncology treatments, ensuring patient-centered care.〖These highlights reflect the partnership’s commitment to fostering innovation, education, and collaboration in integrative oncology, with the shared goal of transf〗integrativeoncology and foster global collaboration in cancer care and research.Signed on November 17, 2024, this partnership establishes a cooperative framework aimed at advancing cancer care through innovation and education.As part of the agreement, OncoDaily becomes WAIO’s Official Media Partner, amplifying the impact of WAIO’s annual meetings, educational programs, and other major initiatives.Key Highlights of the WAIO and OncoDaily PartnershipAdvancing Global Cancer Care and Research◆ Joint efforts to promote integrative oncology as a key approach in improving global cancer care outcomes.◆ Fostering innovation and sharing advancements in oncology practices worldwide.OncoDaily as the Official Media Partner◆ Coverage and promotion of WAIO’s annual meetings, educational events, and significant oncology activities.◆ Amplifying WAIO’s initiatives to a global audience through OncoDaily’s extensive media platform.Educational and Scientific Initiatives◆ Co-hosting global educational and scientific events focused on integrative oncology.◆ Collaborating on the development of joint scientific journals and publications to disseminate cutting-edge research.Global Knowledge Sharing◆ Highlighting WAIO’s contributions, achievements, and advancements in integrative oncology through OncoDaily’s network.◆ Encouraging cross-border collaboration and knowledge exchange among oncology professionals, researchers, and institutions.Holistic Approach to Cancer Care◆ Promoting a model of cancer care that combines traditional healing practices with modern oncology treatments, ensuring patient-centered care.〖These highlights reflect the partnership’s commitment to fostering innovation, education, and collaboration in integrative oncology, with the shared goal of transforming global cancer care. orming global cancer care.〗About World Association for Integrative Oncology (WAIO)WAIO is a non-profit, international oncology association dedicated to promoting holistic cancer care. By integrating traditional and modern oncology approaches, WAIO fosters global collaboration to improve outcomes for cancer patients worldwide.About OncoDailyOncoDaily is a global leader in oncology media, delivering timely news and updates from the field of cancer research, treatment, and advocacy. Guided by the motto “Cancer doesn’t take a day off, neither do we,” OncoDaily remains at the forefront of global oncology communication.This strategic partnership represents a critical step in uniting the global oncology community under the banner of integrative oncology, setting a new standard for collaborative cancer care and research.

We are pleased to announce the upcoming educational events organized by the International Society for Cancer Progression (SPCC) for December 2024. All sessions are certified by the ACOE and are free of charge. These high-quality educational initiatives will have a significant impact on the medical community. We encourage your active participation. Below is an overview of the December activities:1. Immunotherapy and GI cancer. Learnings from the ESMO Congress 2024, ESMO Immuno-Oncology Congress 2024 and Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024Date of the live session: Tuesday, 17th December 2024, at 6:00 pm CETLink to register and access the session:This activity is made possible thanks to educational grants from Astellas and Cloud Pathology Group. Supporting companies have not had any input or influence on its content.2. Haemato-oncology highlights from 66th ASH Annual MeetingDate of the live session: Wednesday, 18th December 2024, at 6:00 pm CETLink to register and access the session: click hereThis activity is made possible thanks to educational grants from Cloud Pathology Group and of Eli Lilly and Company. Supporting companies have not had any input or influence on its content.3. Breast cancer highlights from the San Antonio Breast Cancer Symposium 2024Date of the live session: Thursday, 19th December 2024, at 6:00 pm CETLink to register and access the session: click hereThis activity is made possible thanks to educational grant from Eli Lilly and Company, which has not had any input or influence on its content.